Alemtuzumab as First- and Second-Line Treatment in Patients with Sézary Syndrome-The Experience of a Tertiary Centre
AuthID
P-00Y-ZWH
P-00Y-ZWH
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service